Mabwell updates on clinical progress of 9MW2821 for Triple-Negative Breast Cancer

Minghui Pharmaceutical to present phase I/II study of MHB088C (B7-H3 ADC) for recurrent or metastatic...

Merck to showcase innovative oncology treatments at 2024 ASCO annual meeting